MYO16 c.508-12466A>C

Variant ID: 13-109425517-A-C

NM_001198950.1(MYO16):c.508-12466A>C

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Caspase-mediated cleavage of IRE1 controls apoptotic cell commitment during endoplasmic reticulum stress.

Elife
Shemorry, Anna A; Harnoss, Jonathan M JM; Guttman, Ofer O; Marsters, Scot A SA; Kőműves, László G LG; Lawrence, David A DA; Ashkenazi, Avi A
Publication Date: 2019-08-27

Variant appearance in text: rs2391691
PubMed Link: 31453810
Variant Present in the following documents:
  • Main text
  • elife-47084.pdf
View BVdb publication page



KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.

Cell
Burgess, Michael R MR; Hwang, Eugene E; Mroue, Rana R; Bielski, Craig M CM; Wandler, Anica M AM; Huang, Benjamin J BJ; Firestone, Ari J AJ; Young, Amy A; Lacap, Jennifer A JA; Crocker, Lisa L; Asthana, Saurabh S; Davis, Elizabeth M EM; Xu, Jin J; Akagi, Keiko K; Le Beau, Michelle M MM; Li, Qing Q; Haley, Benjamin B; Stokoe, David D; Sampath, Deepak D; Taylor, Barry S BS; Evangelista, Marie M; Shannon, Kevin K
Publication Date: 2017-02-23

Variant appearance in text: rs2391691
PubMed Link: 28215705
Variant Present in the following documents:
  • Main text
View BVdb publication page



Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening.

Plos One
Tan, Jenille J; Martin, Scott E SE
Publication Date: 2016

Variant appearance in text: rs2391691
PubMed Link: 28030641
Variant Present in the following documents:
  • Main text
  • pone.0168968.pdf
View BVdb publication page



The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.

Elife
Joseph, James D JD; Darimont, Beatrice B; Zhou, Wei W; Arrazate, Alfonso A; Young, Amy A; Ingalla, Ellen E; Walter, Kimberly K; Blake, Robert A RA; Nonomiya, Jim J; Guan, Zhengyu Z; Kategaya, Lorna L; Govek, Steven P SP; Lai, Andiliy G AG; Kahraman, Mehmet M; Brigham, Dan D; Sensintaffar, John J; Lu, Nhin N; Shao, Gang G; Qian, Jing J; Grillot, Kate K; Moon, Michael M; Prudente, Rene R; Bischoff, Eric E; Lee, Kyoung-Jin KJ; Bonnefous, Celine C; Douglas, Karensa L KL; Julien, Jackaline D JD; Nagasawa, Johnny Y JY; Aparicio, Anna A; Kaufman, Josh J; Haley, Benjamin B; Giltnane, Jennifer M JM; Wertz, Ingrid E IE; Lackner, Mark R MR; Nannini, Michelle A MA; Sampath, Deepak D; Schwarz, Luis L; Manning, Henry Charles HC; Tantawy, Mohammed Noor MN; Arteaga, Carlos L CL; Heyman, Richard A RA; Rix, Peter J PJ; Friedman, Lori L; Smith, Nicholas D ND; Metcalfe, Ciara C; Hager, Jeffrey H JH
Publication Date: 2016-07-13

Variant appearance in text: rs2391691
PubMed Link: 27410477
Variant Present in the following documents:
  • Main text
  • elife-15828.pdf
View BVdb publication page



Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Daemen, Anneleen A; Peterson, David D; Sahu, Nisebita N; McCord, Ron R; Du, Xiangnan X; Liu, Bonnie B; Kowanetz, Katarzyna K; Hong, Rebecca R; Moffat, John J; Gao, Min M; Boudreau, Aaron A; Mroue, Rana R; Corson, Laura L; O'Brien, Thomas T; Qing, Jing J; Sampath, Deepak D; Merchant, Mark M; Yauch, Robert R; Manning, Gerard G; Settleman, Jeffrey J; Hatzivassiliou, Georgia G; Evangelista, Marie M
Publication Date: 2015-08-11

Variant appearance in text: rs2391691
PubMed Link: 26216984
Variant Present in the following documents:
  • Main text
View BVdb publication page



Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.

Oncotarget
Wilson, Catherine C; Nicholes, Katrina K; Bustos, Daisy D; Lin, Eva E; Song, Qinghua Q; Stephan, Jean-Philippe JP; Kirkpatrick, Donald S DS; Settleman, Jeff J
Publication Date: 2014-09-15

Variant appearance in text: rs2391691
PubMed Link: 25193862
Variant Present in the following documents:
  • oncotarget-05-7328-s001.pdf
View BVdb publication page